window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 5, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Phase 3 Trials

  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Aravax adds allergy specialists to board as peanut therapy advances

    Aravax has appointed two senior industry figures to its board [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Tozorakimab meets primary endpoint in two Phase 3 COPD trials, showing reduction in exacerbations

    Tozorakimab has met its primary endpoint in two replicate Phase [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Klifo receives regulatory approval for new clinical trial supply facility in Copenhagen

    KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Icotrokinra shows superiority to deucravacitinib in first head-to-head Phase 3 trials for plaque psoriasis

    Johnson & Johnson has reported new data from the Phase [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value

    A new collaborative study from TransCelerate BioPharma and the Tufts [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    MHRA approves Biogen’s tofersen for ultra-rare genetic form of motor neurone disease

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Clinical & Regulatory

    Oculis completes enrollment in DIAMOND Phase 3 trials of OCS-01 for diabetic macular edema

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • University of Huddersfield wins award for 3D wound training models
    Categories: Medical devices
  • Remepy and Merck KGaA partner on hybrid drug programmes
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • RxLogix launches AI pharmacovigilance platform for adverse event monitoring
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top